Cargando…
Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers
New therapeutic modalities for melanoma promise benefit in selected individuals. Efficacy appears greater in patients with lower tumor burden, suggesting an important role for risk‐stratified surveillance. Robust predictive markers might permit optimization of agent to patient, while low‐risk progno...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590387/ https://www.ncbi.nlm.nih.gov/pubmed/30548543 http://dx.doi.org/10.1002/jso.25319 |